1. Response to letter to the editor: catastrophic antiphospholipid antibody syndrome and multiple organ dysfunctions in critically ill patients with COVID-19
    Chiara Robba et al, 2020, Expert Review of Respiratory Medicine CrossRef
  2. Venous thromboembolism in the era of COVID-19
    Konstantinos G Kyriakoulis et al, 2020, Phlebology CrossRef
  3. Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19
    Tania Islam et al, 2020, European Journal of Pharmacology CrossRef
  4. Systemic lupus erythematosus and varicella‐like rash following COVID‐19 in a previously healthy patient
    Yasmine Slimani et al, 2020, J Med Virol CrossRef
  5. Targeting pivotal inflammatory pathways in COVID-19: A mechanistic review
    Akram Yarmohammadi et al, 2020, European Journal of Pharmacology CrossRef
  6. COVID-19 and Hematology—What Do We Know So Far?
    Harshwardhan Khandait et al, 2020, SN Compr. Clin. Med. CrossRef
  7. Emerging Neurological and Psychobiological Aspects of COVID-19 Infection.
    Ferdinando Nicoletti, 0 CrossRef
  8. Host transcriptomic profiling of COVID-19 patients with mild, moderate, and severe clinical outcomes
    Ruchi Jain et al, 2020, Computational and Structural Biotechnology Journal CrossRef
  9. The Covid-19 Arterial Thromboembolic Complications: From Inflammation To Immunothrombosis Through Anti-Phospholipid Autoantibodies
    Luca Roncati et al, 2020, Annals of Vascular Surgery CrossRef
  10. Anti-phospholipids antibodies and immune complexes in COVID-19 patients: a putative role in disease course for anti-annexin-V antibodies
    Antonio Cristiano et al, 2021, Clin Rheumatol CrossRef
  11. Can hydroxychloroquine be protective against COVID-19-associated thrombotic events ?
    Christian A. Devaux et al, 2021, Journal of Microbiology, Immunology and Infection CrossRef
  12. COVID-19 in Association With Development, Course, and Treatment of Systemic Autoimmune Rheumatic Diseases
    Katja Lakota et al, 2021, Front. Immunol. CrossRef
  13. null
    Paolo Bellavite, 2021 CrossRef
  14. SARS-CoV-2 early infection signature identified potential key infection mechanisms and drug targets
    Yue Li et al, 2021, BMC Genomics CrossRef
  15. A network-informed analysis of SARS-CoV-2 and hemophagocytic lymphohistiocytosis genes’ interactions points to Neutrophil extracellular traps as mediators of thrombosis in COVID-19
    Jun Ding et al, 2021, PLoS Comput Biol CrossRef
  16. Do COVID-19 Infections Result in a Different Form of Secondary Hemophagocytic Lymphohistiocytosis
    Raymond Chu et al, 2021, IJMS CrossRef
  17. COVID‐19 (SARS‐CoV‐2) infection and thrombotic conditions: A systematic review and meta‐analysis
    Paulo Roberto Gabbai‐Armelin et al, 2021, Eur J Clin Invest CrossRef
  18. Drug-induced organ injury in coronavirus disease 2019 pharmacotherapy: Mechanisms and challenges in differential diagnosis and potential protective strategies.
    Mohammad Mehdi Ommati et al, 2021, J Biochem Mol Toxicol CrossRef
  19. NOX2 Activation in COVID-19: Possible Implications for Neurodegenerative Diseases
    Cinzia Sindona et al, 2021, Medicina CrossRef
  20. Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature
    Emmanuel J. Favaloro et al, 2021, Semin Thromb Hemost CrossRef
  21. COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check?
    Emmanuel J. Favaloro et al, 2021, Semin Thromb Hemost CrossRef
  22. Neurological and psychological aspects of COVID-19 infection (literature review)
    Svetlana Viktorovna Bulgakova et al, 2021 CrossRef
  23. Comprehensive Review on Neuro-COVID-19 Pathophysiology and Clinical Consequences
    Helia Jafari Khaljiri et al, 2021, Neurotox Res CrossRef
  24. Rheumatological complications of Covid 19
    Hannah Zacharias et al, 2021, Autoimmunity Reviews CrossRef
  25. The Role of Antiphospholipid Antibodies in COVID-19
    Maximilian Stelzer et al, 2021, Curr Rheumatol Rep CrossRef
  26. Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor
    Francisco Javier Gil-Etayo et al, 2021, Biomedicines CrossRef
  27. The protective role of statins in COVID-19 patients: a retrospective observational study
    Srikanth Umakanthan et al, 2021, transl med commun CrossRef
  28. A review of aortic thrombosis in COVID-19 infection
    Korin Karabulut et al, 2021 CrossRef
  29. The PI3K/Akt/mTOR pathway: a potential pharmacological target in COVID-19
    Maria Sofia Basile et al, 2021, Drug Discovery Today CrossRef
  30. Was Antiphospholipid Syndrome a Risk Factor of Stroke? A Systemic Review and Meta-Analysis of Cohort Studies
    Kai Zhao et al, 2021, Disease Markers CrossRef
  31. Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trial
    Connie N. Hess et al, 2022, American Heart Journal CrossRef
  32. Catastrophic antiphospholipid syndrome presented with coronary thrombosis, renal impairment, and suspected diffuse alveolar hemorrhage treated with rituximab biosimilar (CT-P10)
    Changgon Kim et al, 2022, Eur J Inflamm CrossRef
  33. Use and misuse of biomarkers and the role of D-dimer and C-reactive protein in the management of COVID-19: A post-hoc analysis of a prospective cohort study
    Fabio Augusto Rodrigues Gonçalves et al, 2021 CrossRef
  34. Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity
    Otavio Cabral-Marques et al, 2022, Nat Commun CrossRef
  35. null
    Polona Žigon, 2022 CrossRef
  36. ‎Factors associated with coronavirus disease 2019 infection severity among a sample of Lebanese adults: Data from a cross-sectional study.
    Souheil Hallit, 0 CrossRef
  37. Platelet Dysregulation in the Pathobiology of COVID-19
    Rebecca A. Mellema et al, 2022, Hamostaseologie CrossRef
  38. SARS-CoV-2 and Endothelial Cells: Vascular Changes, Intussusceptive Microvascular Growth and Novel Therapeutic Windows
    Antonio Giovanni Solimando et al, 2022, Biomedicines CrossRef
  39. Molecular Pathogenesis of Endotheliopathy and Endotheliopathic Syndromes, Leading to Inflammation and Microthrombosis, and Various Hemostatic Clinical Phenotypes Based on “Two-Activation Theory of the Endothelium” and “Two-Path Unifying Theory” of Hemostasis
    Jae C. Chang, 2022, Medicina CrossRef
  40. A Review Pertaining to SARS-CoV-2 and Autoimmune Diseases: What Is the Connection?
    Nina Kocivnik et al, 2022, Life CrossRef
  41. Longitudinal Analysis of Antiphospholipid Antibody Dynamics after Infection with SARS-CoV-2 or Vaccination with BNT162b2
    Manca Ogrič et al, 2022, IJMS CrossRef
  42. Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19
    Florian Tran et al, 2022, ERJ Open Res CrossRef
  43. null
    Prashant S. Giri et al, 2022 CrossRef
  44. null
    Prashant S. Giri et al, 2022 CrossRef
  45. null
    Claudia Mendoza-Pinto et al, 2022 CrossRef
  46. Pyroptosis, Apoptosis, and Autophagy: Critical Players of Inflammation and Cell Demise in the Nervous System
    Kenneth Maiese, 2022, CNR CrossRef
  47. Shared 6mer Peptides of Human and Omicron (21K and 21L) at SARS-CoV-2 Mutation Sites
    Yekbun Adiguzel et al, 2022, Antibodies CrossRef
  48. Co-infection associated with SARS-CoV-2 and their management
    Vivek P Chavda et al, 2023, Future Science OA CrossRef
  49. null
    Arad Dotan et al, 2023 CrossRef
  50. null
    Yekbun Adiguzel et al, 2023 CrossRef
  51. null
    Natalia Gavrilova et al, 2023 CrossRef
  52. Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium
    Otávio Cabral-Marques et al, 2023, Autoimmunity Reviews CrossRef
  53. Anti-COVID-19 Potential of Ellagic Acid and Polyphenols of Punica granatum L.
    Ralitza Alexova et al, 2023, Molecules CrossRef
  54. Cellular Metabolism: A Fundamental Component of Degeneration in the Nervous System
    Kenneth Maiese, 2023, Biomolecules CrossRef
  55. Advances in Management of the Stroke Etiology One-Percenters
    Nicholas D. Osteraas et al, 2023, Curr Neurol Neurosci Rep CrossRef
  56. The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk
    Kenneth Maiese, 2023, Front. Immunol. CrossRef
  57. Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approach
    Dennyson Leandro M. Fonseca et al, 2023, npj Aging CrossRef
  58. Antiphospholipid antibodies are enriched post-acute COVID-19 but do not modulate the thrombotic risk
    Marc Emmenegger et al, 2023, Clinical Immunology CrossRef
  59. Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines
    Altijana Hromić-Jahjefendić et al, 2023, Autoimmunity Reviews CrossRef
  60. null
    Paula David, 2024 CrossRef
  61. Antiphospholipid syndrome, thrombosis, and vaccination in the COVID-19 pandemic
    Tatjana Zekić et al, 2024, Rheumatol Int CrossRef